Diseases of Memory

Zhittya Genesis Medicine is investigating the potential of its proprietary Fibroblast Growth Factor 1 (FGF-1) therapy to treat memory-related diseases, such as Alzheimer's disease and vascular dementia. Emerging research indicates that these conditions may originate from vascular disruptions within the brain, leading to reduced blood flow and subsequent neuronal damage. FGF-1 is a potent stimulator of angiogenesis—the growth of new blood vessels—and has demonstrated the ability to restore blood flow in ischemic tissues. By promoting angiogenesis, FGF-1 aims to re-establish proper vascular function in affected brain regions, potentially halting or even reversing the progression of these neurodegenerative diseases. Zhittya's innovative approach offers hope for millions suffering from memory disorders by addressing their underlying vascular components.